ANDA 212814, held by Vistapharm LLC. Aminocaproic Acid.
As of Nov 15, 2026, ANDA 212814 (Aminocaproic Acid), held by Vistapharm LLC, was first approved by FDA on Feb 26, 2020, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Feb 26, 2020 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Aminocaproic Acid0.25GM/ML ยท solution;oral | Aminocaproic Acid | Discontinued |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters
